Results 301 to 310 of about 9,057,553 (322)

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

X‐chromosome inactivation in female patients with Fabry disease

Clinical Genetics, 2016
L. Echevarría, K. Bénistan, A. Toussaint, O. Dubourg, A. Hagège, D. Eladari, F. Jabbour, C. Beldjord, P. Mazancourt, Dominique P. Germain   +9 more
semanticscholar   +1 more source

When and How to Diagnose Fabry Disease in Clinical Pratice.

American Journal of the Medical Sciences, 2020
M. Michaud, W. Mauhin, N. Belmatoug, R. Garnotel, N. Bedreddine, F. Catros, S. Ancellin, O. Lidove, F. Gaches   +8 more
semanticscholar   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Marsela Braunstein, Stephanie Lheureux, Amit M Oza   +2 more
exaly  

Fabry's Disease

New England Journal of Medicine, 1967
openaire   +2 more sources

Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2018
Nancy D Perrier, Tf Duffield, R Michael Tuttle   +2 more
exaly  

Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement

Clinical pharmacology and therapy, 2018
N. Guérard, D. Oder, P. Nordbeck, C. Zwingelstein, O. Morand, R. Welford, J. Dingemanse, C. Wanner   +7 more
semanticscholar   +1 more source

Fabry Disease

2014
Gere Sunder-Plassmann, Manuela Födinger, Renate Kain   +2 more
openaire   +2 more sources

Neurology in fabry disease

Clinical Therapeutics, 2008
Anette Torvin Møller, Troels S. Jensen
openaire   +3 more sources

Colorectal cancer statistics, 2020

Ca-A Cancer Journal for Clinicians, 2020
Rebecca L Siegel, Kimberly D Miller, Stacey A Fedewa   +2 more
exaly